Hubei Biocause Pharmaceutical Co., Ltd. Stock Price

SZSE:000627 Community·CN¥7.7b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

000627 Share Price Performance

CN¥1.58

-2.32 (-59.49%)

CN¥1.58

-2.32 (-59.49%)

CN¥1.58

Sat, 7 Mar 26

Share Pricen/a

000627 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks

0 Rewards

View Full Analysis

Hubei Biocause Pharmaceutical Co., Ltd. Key Details

Last Reported Earnings

Sep 30, 2024

Next Reporting Earnings

n/a

: -0.16
: 4.12%
: -1.90%
: 48.6%

View Full Analysis

About 000627

Founded: n/a
Employees: 1765
CEO: Wenxia Zhou
WebsiteView website: www.biocause.com/

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.